Power Company CEO Fesses Up, Boston Is Screwed

Friends…

On October 27, the CEO of New England's largest energy company sent a desperate letter to the White House.

“This represents a serious public health and safety threat,” Eversource CEO Joe Nolan wrote in a letter to President Joe Biden.

He then begged Joe Biden to use the federal government's emergency powers to make sure natural gas will be available in New England this winter.

There's only one problem.

There's nothing Biden or anyone can do at this point. All available natural gas is on its way to Europe.

When large parts of New England go dark and freeze this winter, a lot of people will call it a shocking natural disaster. Or they'll say it was because Russia invaded Ukraine. But cities don't go dark and freeze in the wealthiest country in the world by accident.

My name is Porter Stansberry. I'm the founder of one of the world's largest financial research firms.

I've spent the last two years researching this coming crisis. I've been writing about it in my newsletter, The Big Secret on Wall Street, since June…

And now that this crisis is set to unfold, exactly the way I've been predicting, I've uploaded an eye-opening video that tells the whole sordid tale. I name names in it. And I reveal who caused this crisis, and why…

Do yourself a favor. Before it's taken offline – which could happen at any time – check out this shocking video.

I've seen in the past just how far powerful people will go to silence me.

Sincerely,

Porter Stansberry

P.S. In the video, about halfway through, I reveal a way you could make 10-50x returns on an American energy company that's set to go up like a moonshot if the lights go out in Boston this winter…

Don't miss this: CLICK HERE.

Don’t Stop Here

More To Explore

Market Brief: AI Risks and Fed Minutes Incoming

Market Snapshot Market Pulse: U.S. stocks edged sideways, buoyed by fresh AI chatter that kept tech afloat while industrial sectors shrugged off supply-chain jitters. Bond

AARD: 56% Drop Sparks Urgent Investor Scrutiny!

Overview: Aardvark Therapeutics, Inc. (Nasdaq: AARD) is a clinical-stage biotech focused on therapies for metabolic diseases and Prader-Willi Syndrome (PWS) – a rare genetic disorder

Gene-Editing Goldrush Meets AI and ETF Plays

Opening Recap Market Pulse: Gene-editing fervor rippled through biotech circles after a Mordor Intelligence report flagged double-digit growth in cell line development through 2031. Down